HAE
Haemonetics Corporation
105.30$
-0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 43.0% | 34.8% | 35.0% | 38.5% | 37.9% | 39.7% | 38.1% | 37.1% | 36.8% | 37.9% | 34.8% | 34.3% | |
| 17.5% | 8.8% | 8.1% | 13.6% | 11.9% | 12.7% | 12.5% | 11.9% | 12.1% | 14.6% | 10.2% | 9.4% | |
| 17.5% | 8.8% | 8.1% | 13.6% | 11.9% | 12.7% | 12.5% | 11.9% | 12.1% | 14.6% | 10.2% | 9.4% | |
| 8.7% | 9.6% | 9.4% | 7.9% | 8.5% | 8.4% | 8.3% | 8.2% | 8.5% | 7.9% | 9.1% | 9.1% | |
| 14.2% | 13.8% | 14.4% | 14.7% | 15.1% | 14.2% | 14.9% | 14.6% | 13.8% | 12.9% | 12.8% | 13.0% | |
| 15.3% | – | – | – | 11.9% | 11.3% | 11.6% | 11.7% | 12.0% | 11.9% | – | – | |
| 23.1% | 25.2% | 25.7% | 24.1% | 24.4% | 23.9% | 24.7% | 24.7% | 24.8% | 24.4% | 27.4% | 27.8% | |
| 12.5% | 19.5% | 18.5% | 19.5% | 19.3% | 18.4% | 18.6% | 18.3% | 17.5% | 16.9% | 18.7% | 18.4% | |
| 55.6% | 57.1% | 56.3% | 64.4% | 65.2% | 64.2% | 66.5% | 64.2% | 65.2% | 63.4% | 66.8% | 64.6% | |
| 13.1% | 11.9% | 13.7% | 10.2% | 10.8% | 10.0% | 23.6% | 21.6% | 22.5% | 21.7% | 11.8% | 11.1% | |
| 0.7% | 0.6% | 0.5% | 0.2% | 0.2% | 0.2% | 12.4% | 12.3% | 12.5% | 12.2% | 0.2% | 0.2% | |
| 4.0% | 2.6% | 3.3% | 3.0% | 2.7% | 2.5% | 2.7% | 1.9% | 2.5% | 2.0% | 2.1% | 2.4% | |
| 37.2% | 38.9% | 36.3% | 48.0% | 48.3% | 48.2% | 37.6% | 37.4% | 37.7% | 36.9% | 50.9% | 49.4% | |
| 44.4% | 42.9% | 43.7% | 35.6% | 34.8% | 35.8% | 33.5% | 35.8% | 34.8% | 36.6% | 33.2% | 35.4% | |
| 15.4% | 15.5% | 16.4% | 15.2% | 14.6% | 15.5% | 14.4% | 14.5% | 13.8% | 15.3% | 11.7% | 13.2% | |
| 2.6% | 2.3% | 2.3% | 2.0% | 2.0% | 2.0% | 2.0% | 2.0% | 2.0% | 1.9% | 1.9% | 1.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.